1 active not recruiting, 1 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
Follow Advanced Cervical Adenocarcinoma: new trials by email Literature Review of Advanced Cervical Adenocarcinoma trials Research Report on Advanced Cervical Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer Biospecimen Collection, Brachytherapy, Cisplatin - Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 21 | 2019-09-18 | 2026-10-30 |
| Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers Durvalumab, Laboratory Biomarker Analysis, Stereotactic Radiosurgery - Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma | Phase 1 | Completed | M.D. Anderson Cancer Center | 20 | 2018-07-18 | 2023-09-13 |
Uterine Cervical Neoplasms (2) · Vaginal Neoplasms (1) · Vulvar Neoplasms (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Neoplasms (2) · Neoplasms by Site (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Uterine Cervical Diseases (2) · Uterine Diseases (2) · Uterine Neoplasms (2) · Vaginal Diseases (1) · Vulvar Diseases (1)
1,2-diaminocyclohexaneplatinum II citrate (1) · 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (1) · Brachytherapy (1) · Cisplatin (1) · Congresses as Topic (1) · Disulfides (1) · Fluorodeoxyglucose F18 (1) · Immunoglobulin G (1) · Magnetic Resonance Spectroscopy (1) · Platinum (1) · Radiation (1) · Radiosurgery (1) · Radiotherapy, Intensity-Modulated (1) · Specimen Handling (1) · durvalumab (1)
M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1)
United States (2)
Lilie L Lin (1) · Sarah E Taylor (1)
UM1CA186690 (1)